Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction.

Source:http://linkedlifedata.com/resource/pubmed/id/19897079

Download in:

View as

General Info

PMID
19897079